Welcome to the Hardcore Husky Forums. Folks who are well-known in Cyberland and not that dumb.
Florida Seeking Monoclonal Supplies From Glaxo Smith Kline
AtomicPiss
Administrator, Swaye's Wigwam Posts: 64,523 
BY PATRICIA TOLSON September 17, 2021
Following the Biden administration’s surprise announcement that Health and Human Services (HHS) is taking over the distribution of monoclonal antibody infusion treatments for COVID-19—reducing the number of doses in several red states by 50 percent—a spokesperson for Florida Gov. Ron DeSantis said he has reached out to Glaxo Smith Kline to “fill the deficit.”
Some states are set to receive fewer doses of monoclonal antibody treatments after the Biden administration switched the distribution system this week. Florida, Alabama, Texas, Tennessee are among the states targeted to have their monoclonal antibody (mAb) doses restricted by HHS.
“HHS will determine the amount of product each state and territory receives on a weekly basis,” a Health a Human Services spokesman said. “State and territorial health departments will subsequently identify sites that will receive product and how much. This system will help maintain equitable distribution, both geographically and temporally, across the country—providing states and territories with consistent, fairly-distributed supply over the coming weeks.”
Noting that there have been no reported shortages of the treatment, Biden’s press secretary Jen Psaki was asked why the government feels it’s necessary to reduce doses to states like Florida, which has a greater need. Psaki reiterated the standard of “equity” as the reason for taking over distribution.
“Our supply is not unlimited,” Psaki insisted, “and we believe it should be equitable across states across the country.”
“The Biden administration did not give the Florida Department of Health or healthcare providers in Florida any notice or time to prepare for this immediate deficit,” Christina Pushaw, press secretary for the Executive Office of DeSantis told The Epoch Times. “There is no evidence of a national shortage of monoclonal antibody treatments, and no apparent justification for rationing. The excuse given by the Biden administration was ‘equity.’ Governor DeSantis spoke with Glaxo Smith Kline leadership yesterday afternoon. GSK makes their own version of monoclonals that works just as well if not better than Regeneron. The Feds haven’t bought GSK supply, only Regeneron and Eli Lilly.
“The Biden administration and their allies in media have claimed that Florida is using too much monoclonal treatment because of a low vaccination rate,” Pushaw said further, “and Biden has lashed out at Governor DeSantis for opposing the tyrannical federal vaccine mandate. But Florida has a higher than average vaccination rate compared to other states. More than half the patients at some of the state monoclonal sites in Florida are fully vaccinated. They still need monoclonal antibody treatment to avoid hospitalization and death, especially if they are in high-risk groups.”
At a press conference in Broward County on Thursday DeSantis said: “We are very, very concerned with the Biden administration and the HHS’s recent abrupt sudden announcement that they are going to dramatically cut the number of monoclonal antibodies that are going to be sent to the State of Florida. Just last week on September 9, president Joe Biden said that his administration would be increasing shipments of monoclonal antibodies in September by 50 percent, and yet on September 13, HHS announced that it was seizing control of the monoclonal antibody supply and that it would control distribution. And then on September 14, the announcement was more than 50 percent of the monoclonal antibodies that had been used in Florida were going to be reduced.”
Pushaw said HHS officials told states earlier this month that they would more closely scrutinize how many of the treatments were actually being used but that the department was not going to throttle the state supplies.
Following the Biden administration’s surprise announcement that Health and Human Services (HHS) is taking over the distribution of monoclonal antibody infusion treatments for COVID-19—reducing the number of doses in several red states by 50 percent—a spokesperson for Florida Gov. Ron DeSantis said he has reached out to Glaxo Smith Kline to “fill the deficit.”
Some states are set to receive fewer doses of monoclonal antibody treatments after the Biden administration switched the distribution system this week. Florida, Alabama, Texas, Tennessee are among the states targeted to have their monoclonal antibody (mAb) doses restricted by HHS.
“HHS will determine the amount of product each state and territory receives on a weekly basis,” a Health a Human Services spokesman said. “State and territorial health departments will subsequently identify sites that will receive product and how much. This system will help maintain equitable distribution, both geographically and temporally, across the country—providing states and territories with consistent, fairly-distributed supply over the coming weeks.”
Noting that there have been no reported shortages of the treatment, Biden’s press secretary Jen Psaki was asked why the government feels it’s necessary to reduce doses to states like Florida, which has a greater need. Psaki reiterated the standard of “equity” as the reason for taking over distribution.
“Our supply is not unlimited,” Psaki insisted, “and we believe it should be equitable across states across the country.”
“The Biden administration did not give the Florida Department of Health or healthcare providers in Florida any notice or time to prepare for this immediate deficit,” Christina Pushaw, press secretary for the Executive Office of DeSantis told The Epoch Times. “There is no evidence of a national shortage of monoclonal antibody treatments, and no apparent justification for rationing. The excuse given by the Biden administration was ‘equity.’ Governor DeSantis spoke with Glaxo Smith Kline leadership yesterday afternoon. GSK makes their own version of monoclonals that works just as well if not better than Regeneron. The Feds haven’t bought GSK supply, only Regeneron and Eli Lilly.
“The Biden administration and their allies in media have claimed that Florida is using too much monoclonal treatment because of a low vaccination rate,” Pushaw said further, “and Biden has lashed out at Governor DeSantis for opposing the tyrannical federal vaccine mandate. But Florida has a higher than average vaccination rate compared to other states. More than half the patients at some of the state monoclonal sites in Florida are fully vaccinated. They still need monoclonal antibody treatment to avoid hospitalization and death, especially if they are in high-risk groups.”
At a press conference in Broward County on Thursday DeSantis said: “We are very, very concerned with the Biden administration and the HHS’s recent abrupt sudden announcement that they are going to dramatically cut the number of monoclonal antibodies that are going to be sent to the State of Florida. Just last week on September 9, president Joe Biden said that his administration would be increasing shipments of monoclonal antibodies in September by 50 percent, and yet on September 13, HHS announced that it was seizing control of the monoclonal antibody supply and that it would control distribution. And then on September 14, the announcement was more than 50 percent of the monoclonal antibodies that had been used in Florida were going to be reduced.”
Pushaw said HHS officials told states earlier this month that they would more closely scrutinize how many of the treatments were actually being used but that the department was not going to throttle the state supplies.
Comments
Some states are set to receive fewer doses of monoclonal antibody treatments after the Biden administration switched the distribution system this week. Florida, Alabama, Texas, Tennessee are among the states targeted to have their monoclonal antibody (mAb) doses restricted by HHS.
“HHS will determine the amount of product each state and territory receives on a weekly basis,” a Health a Human Services spokesman said. “State and territorial health departments will subsequently identify sites that will receive product and how much. This system will help maintain equitable distribution, both geographically and temporally, across the country—providing states and territories with consistent, fairly-distributed supply over the coming weeks.”
Noting that there have been no reported shortages of the treatment, Biden’s press secretary Jen Psaki was asked why the government feels it’s necessary to reduce doses to states like Florida, which has a greater need. Psaki reiterated the standard of “equity” as the reason for taking over distribution.
“Our supply is not unlimited,” Psaki insisted, “and we believe it should be equitable across states across the country.”
“The Biden administration did not give the Florida Department of Health or healthcare providers in Florida any notice or time to prepare for this immediate deficit,” Christina Pushaw, press secretary for the Executive Office of DeSantis told The Epoch Times. “There is no evidence of a national shortage of monoclonal antibody treatments, and no apparent justification for rationing. The excuse given by the Biden administration was ‘equity.’ Governor DeSantis spoke with Glaxo Smith Kline leadership yesterday afternoon. GSK makes their own version of monoclonals that works just as well if not better than Regeneron. The Feds haven’t bought GSK supply, only Regeneron and Eli Lilly.
“The Biden administration and their allies in media have claimed that Florida is using too much monoclonal treatment because of a low vaccination rate,” Pushaw said further, “and Biden has lashed out at Governor DeSantis for opposing the tyrannical federal vaccine mandate. But Florida has a higher than average vaccination rate compared to other states. More than half the patients at some of the state monoclonal sites in Florida are fully vaccinated. They still need monoclonal antibody treatment to avoid hospitalization and death, especially if they are in high-risk groups.”
At a press conference in Broward County on Thursday DeSantis said: “We are very, very concerned with the Biden administration and the HHS’s recent abrupt sudden announcement that they are going to dramatically cut the number of monoclonal antibodies that are going to be sent to the State of Florida. Just last week on September 9, president Joe Biden said that his administration would be increasing shipments of monoclonal antibodies in September by 50 percent, and yet on September 13, HHS announced that it was seizing control of the monoclonal antibody supply and that it would control distribution. And then on September 14, the announcement was more than 50 percent of the monoclonal antibodies that had been used in Florida were going to be reduced.”
Pushaw said HHS officials told states earlier this month that they would more closely scrutinize how many of the treatments were actually being used but that the department was not going to throttle the state supplies.
Perfect experiment to watch how centrally planned, politically motivated healthcare kills people on purpose.